Side effects of misoprostol therapy during pregnancy;Nebenwirkungen von misoprostol beim einsatz im rahmen der schwangerschaft

Zeitschrift fur Geburtshilfe und Neonatologie

Volumn 205, Issue 2, 2001, Pages 43-48

  Zust S ^a   Hosli I ^a   Surbek, D ^a   Holzgreve, W ^a  

^a UNIVERSITY WOMEN S HOSPITAL   (Switzerland)

Author keywords

Cervical ripening; Hyperstimulation syndrome; Induction of abortion; Misoprostol; Postpartal hemorrhage; Uterine rupture

Indexed keywords

MISOPROSTOL; PROSTAGLANDIN E1 DERIVATIVE;

ABORTION; ARTICLE; HUMAN; INDUCED ABORTION; LABOR INDUCTION; POSTPARTUM HEMORRHAGE; PREGNANCY TERMINATION; SIDE EFFECT; UTERUS RUPTURE;

EID: 0035033171     PISSN: 09482393     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2001-14819     Document Type: Article

References (40)

1. In vitro characterisation of prostanoid receptors on human myometrium at term pregnancy
2. Absorption kinetics of misoprostol with oral or vaginal administration
3. Rectally administered misoprostol for the treatment of postpartum hemorrhage unresponsive to oxytocin and ergometrine: A descriptive study
4. Randomized comparison of rectal misoprostol with Syntometrine for management of third stage labor
5. Rectal misoprostol in the prevention of postpartum hemorrhage: A placebo-controlled trial
6. Uterine contractility and induction of abortion in early pregnancy by misoprostol and mifepristone
7. Misoprostol and illegal abortion in Rio de Janeiro, Brazil
8. Limb deficiency with or without Mobius sequence in seven Brazilian children associated with misoprostol use in the first trimester of pregnancy
9. Use of misoprostol during pregnancy and Mobius' syndrome in infants
10. Congenital abnormalities in Brazilian children associated with misoprostol misuse in first trimester of pregnancy
11. Misoprostol and congenital malformations
12. Medical versus surgical abortion
13. Medical. Medical abortion in China
14. Misoprostol in obstetrics and gynaecology - Unregistered, dangerous and essential. Editorial
15. Vaginal misoprostol compared with vaginal gemeprost in termination of second trimester pregnancy. A randomized trial
16. A comparison of two dosing regimens of intravaginal misoprostol for second-trimester pregnancy termination
17. A comparison of intravaginal misoprostol and intracervical prostaglandin E2 gel for ripening of unfavourable cervix and labor induction
18. Medical management of missed abortion and anembryonic pregnancy
19. Unsuccessful treatment of missed abortion
20. Unsuccessful treatment of missed abortion with a combination of an antiprogesterone and a prostaglandin E1 analogue
21. Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion
22. Prostaglandins in preinduction cervical ripening: Meta-analysis of worldwide clinical experience
23. Randomised trial of one versus two doses of prostaglandin E2 for induction of labour: 1. Clinical outcome
24. Misoprostol for induction of labour: A systematic review
25. Uterine hyperstimulation after low-dose prostaglandin E2 therapy: Tocolytic treatment in 181 cases
26. Use of misoprostol for labour induction in stillbirths
27. Padrao tocografico desencadeado pelo misoprostol
28. Labor induction with misoprostol
29. Labor induction with intravaginal misoprostol in term premature rupture of membranes: A randomized study
30. A comparison of misoprostol and prostaglandin E2 gel for preinduction cervical ripening and labor induction
31. Misoprostol: An effective agent for cervical ripening and labor induction
32. A comparison of differing dosing regimens of vaginally administered misoprostol for preinduction cervical ripening and labor induction
33. A comparison of intermittent vaginal administration of misoprostol with continous dinoprostone for cervical ripening and labor induction
34. Vaginally administered misoprostol (Cytotec) versus the dinoprostone vaginal insert (Cervidil) for preinduction cervical ripening and labor induction
35. Induction of labour with misoprostol in the second and third trimesters of pregnancy
36. Experience with vaginal and rectal misoprostol as an oxytocic agent in pregnancy
37. Oral misoprostol for third stage of labor: A randomized placebo-controlled trial
38. Mis oprostol dose-related shivering and pyrexia in the third stage of labour
39. A randomised placebo controlled trial of oral misoprostol in the third stage of labour
40. Use of oral misoprostol in the prevention of postpartume haemorrhage